Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v4-EN
Language French English
Date Updated 2018-03-23 2017-11-15
Drug Identification Number 00594377 00594377
Brand name ALDACTAZIDE 50 ALDACTAZIDE 50
Common or Proper name ALDACTAZIDE ALDACTAZIDE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROCHLOROTHIAZIDE SPIRONOLACTONE HYDROCHLOROTHIAZIDE SPIRONOLACTONE
Strength(s) 50MG 50MG 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 TAB/BTL 100 TAB/BTL
ATC code C03EA C03EA
ATC description DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-06
Actual start date 2017-11-08
Estimated end date 2018-02-26
Actual end date 2018-03-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments